A Clinical study to understand the effect and safety of new treatment on patients with kidney problem
Not Applicable
Completed
- Conditions
- Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)
- Registration Number
- CTRI/2019/01/017070
- Lead Sponsor
- Myline Biotech India Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Subjects aged between 18 and 70yrs
2 Stage 3 4 and 5
3 Patients wanting to delay dialysis.
4 Willing to come for regular follow up visits
5 Able to give written informed consent
Exclusion Criteria
1 Pregnant and lactation.
2 Autoimmune disease e g SLE/Vasculities
3 Subjects with hepatic impairement (SGOT or SGPT levels more than 3 times the upper limit)
4 Diabetic foot infection patients
5 Subjects with uncontrolled cardiovascular events.
6 Patients who have been prescribed Synbiotics and Enzymes.
7Subjects with any other severe systemic illness and in the opinion of the investigator would be non compliant with the visit schedule or study procedures.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method